MLA
Iles, Kathleen A, et al. Bridging Endocrine Therapy for Hr+/her2- Resectable Breast Cancer: Is it Safe?. SAGE Publications, 2022. https://doi.org/10.17615/mmw7-9v67
APA
Iles, K., Thornton, M., Park, J., Roberson, M., Spanheimer, P., Ollila, D., & Gallagher, K. (2022). Bridging Endocrine Therapy for HR+/HER2- Resectable Breast Cancer: Is it Safe?. SAGE Publications. https://doi.org/10.17615/mmw7-9v67
Chicago
Iles, Kathleen A., Madeline Thornton, Jihye Park, Mya Roberson, Philip M Spanheimer, David W Ollila, and Kristalyn Gallagher. 2022. Bridging Endocrine Therapy for Hr+/her2 Resectable Breast Cancer: Is it Safe?. SAGE Publications. https://doi.org/10.17615/mmw7-9v67